- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01036308
Intervention With Legume Kernel Fibre in Healthy Subjects
Comparison of the Effects of Three Native Legume Kernel Fibres on Cholesterol Metabolism in Healthy Subjects
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Dietary fibre is suspected to effect the faecal concentration and excretion of bile acids by binding the bile acids and by increasing the faecal mass. Bile acids, especially the secondary bile acids, are potential risk factors for colorectal cancer. A high bile acid-binding ability of fibre could lead to lower serum cholesterol concentrations by interrupting the enterohepatic circulation. There is evidence that the consumption of legume kernel fibre, containing both soluble and insoluble fibre fractions, may beneficially modify bowel health.
Seventy-eight healthy volunteers were enrolled. Seventy-six subjects (mean age of 24 years, 55 women and 21 men) completed the double-blind, randomized crossover trial. After two weeks run-in period, half of the volunteers consumed 25 g of legume fibres (Boregine, TypTop or Soy fibre) every day, and the other half received a reference fibre product (citrus fibre, Herbacel AQ Plus) for a period of two weeks. After two weeks wash-out the intervention changed between the groups.
At the end of each period a quantitative stool and urine collection took place and fasting blood samples were drawn.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Thuringia
-
Jena, Thuringia, Germany, D-07743
- Friedrich Schiller University Jena, Institute of Nutrition, Department of Nutrional Physiology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age 20-45 years
- healthy subjects
Exclusion Criteria:
- intake of pharmaceuticals and nutritional supplements
- allergy against legumes
- intolerance against milk protein
- pregnancy, lactation
- chronic diseases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: TypTop
Lupinus albus Typ Top (lupin kernel fibre, dietary fibre content: 83%)
|
The subjects consumed 25 g pure fibre-product per day over two weeks.
One half a portion of the fibres was stirred into a selected milk product and the other half in juice.
The subjects consumed 25 g reference fibre (citrus fibre: Herbacel AQ Plus; Herbafood Ingredients) per day over two weeks.
One half a portion of the fibres was stirred into a selected milk product and the other half in juice.
Other Names:
|
|
Experimental: Soy fibre
Glycine max Hefeng (soy fibre; dietary fibre content: 77%)
|
The subjects consumed 25 g pure fibre-product per day over two weeks.
One half a portion of the fibres was stirred into a selected milk product and the other half in juice.
The subjects consumed 25 g reference fibre (citrus fibre: Herbacel AQ Plus; Herbafood Ingredients) per day over two weeks.
One half a portion of the fibres was stirred into a selected milk product and the other half in juice.
Other Names:
|
|
Experimental: Boregine
Lupinus angustifolius Boregine (lupin kernel fibre, dietary fibre content: 87%)
|
The subjects consumed 25 g pure fibre-product per day over two weeks.
One half a portion of the fibres was stirred into a selected milk product and the other half in juice.
The subjects consumed 25 g reference fibre (citrus fibre: Herbacel AQ Plus; Herbafood Ingredients) per day over two weeks.
One half a portion of the fibres was stirred into a selected milk product and the other half in juice.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes of serum lipids (cholesterol metabolism)
Time Frame: after 2, 4 and 8 weeks
|
after 2, 4 and 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes of general excretion parameters, neutral sterols, bile acids, short-chain fatty acids, fibre excretion
Time Frame: after 2, 4 and 8 weeks
|
after 2, 4 and 8 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Gerhard Jahreis, Prof. Dr., Friedrich Schiller University Jena, Institute of Nutrition, Department of Nutrional Physiology
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- LSEP H32-07
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.